Reaction: Omidenepag isopropyl to 1 product

Reaction
Omidenepag isopropyl
DB15071
Omidenepag
DBMET03559
Reaction type
esterase hydrolysis
Direction
Major circulating metabolite?
Yes
Spontaneous?
No
Activity
active
References
  1. FDA Approved Drug Products: OMLONTI (omidenepag isopropyl) ophthalmic solution 0.002%, for topical ophthalmic use [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
CarboxylesteraseNot AvailableNot Availableconfirmed